pre-miRNA Information
pre-miRNA hsa-mir-4532   
Genomic Coordinates chr20: 57895394 - 57895444
Description Homo sapiens miR-4532 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-4532
Sequence 6| CCCCGGGGAGCCCGGCG |22
Evidence Experimental
Experiments Illumina
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol PTGES2   
Synonyms C9orf15, GBF-1, GBF1, PGES2, mPGES-2
Description prostaglandin E synthase 2
Transcript NM_025072   
Other Transcripts NM_198938   
Expression
Putative miRNA Targets on PTGES2
3'UTR of PTGES2
(miRNA target sites are highlighted)
>PTGES2|NM_025072|3'UTR
   1 ATGTCCCCGCGCAGAGCAGAGGGAAGGCAGCGGAAGACGCCAGCTGCCAGGGCCTGGGGCCACTGGGCCAGCGCCTGGCG
  81 ATACTGGTTGGGGGCAGGATCATTCTGCCCCTTGTCCACGCACCCCCACCAGCCCTCTCGCTTCTAACACAGGGCACCTG
 161 CTGGGGCTCAGGGATGTTAGGGACGAGTTCCAGCCCTGCCACTGCCCTGGGGCGACCCCTCCCTGTCCCTGCCTCCCTGC
 241 TCTGCCGCCCCTCTTCCTGGACCCTCAGTGGCTGTCCCATGGCTACATCCTGTGGGTGGGGGCCCTCGACAGGACAGCAG
 321 GACGGTTTGTTTTCAGTGGAATCCCATCCCTGGGTTCCCCTGGTTCCCACTCTTCCCAAGCCTCCCGGGACTGGGACATG
 401 TTTGCAATAAAGGAAAGGTTTGTGGCGCCTGTCATGGCAGGCATCTCATGGAAAAAAAAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' gcGGCCCGAGGGGCCCc 5'
            |:|||:||||| || 
Target 5' ccCTGGGTTCCCCTGGt 3'
348 - 364 135.00 -23.70
2
miRNA  3' gcGGCCCGAGGGGCCCc 5'
            ||  || :|||||| 
Target 5' tcCCAAGCCTCCCGGGa 3'
374 - 390 135.00 -18.70
3
miRNA  3' gcggcccGA-GGGGCCCc 5'
                 || |||:||| 
Target 5' cctgccaCTGCCCTGGGg 3'
195 - 212 126.00 -22.20
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN31587838 89 COSMIC
COSN23017309 97 COSMIC
COSN30528813 140 COSMIC
COSN30143687 195 COSMIC
COSN28201542 278 COSMIC
COSN31778738 308 COSMIC
COSN7557208 311 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs980223008 2 dbSNP
rs1396872058 5 dbSNP
rs1300120186 7 dbSNP
rs201238358 8 dbSNP
rs746405466 9 dbSNP
rs1174396202 10 dbSNP
rs531086318 11 dbSNP
rs973864913 16 dbSNP
rs1198714481 21 dbSNP
rs1438763061 23 dbSNP
rs1277262734 28 dbSNP
rs201789766 31 dbSNP
rs751279204 32 dbSNP
rs1481901451 35 dbSNP
rs1335855120 36 dbSNP
rs574737432 38 dbSNP
rs554731903 39 dbSNP
rs1346448369 41 dbSNP
rs370822041 43 dbSNP
rs765127404 44 dbSNP
rs1232360272 47 dbSNP
rs759431217 48 dbSNP
rs776574800 49 dbSNP
rs891086522 53 dbSNP
rs1273663543 63 dbSNP
rs995607081 72 dbSNP
rs1028410476 73 dbSNP
rs1037109590 79 dbSNP
rs997315796 88 dbSNP
rs1196933403 91 dbSNP
rs907352998 92 dbSNP
rs904032645 96 dbSNP
rs1047453 105 dbSNP
rs1388737319 109 dbSNP
rs1046042805 117 dbSNP
rs1043943707 119 dbSNP
rs762416785 120 dbSNP
rs892760285 123 dbSNP
rs1056698249 124 dbSNP
rs541136618 125 dbSNP
rs1323376901 131 dbSNP
rs948957258 132 dbSNP
rs1441184478 135 dbSNP
rs572160832 139 dbSNP
rs558696738 142 dbSNP
rs1047460 144 dbSNP
rs539057146 147 dbSNP
rs1251668754 148 dbSNP
rs146605618 152 dbSNP
rs928268365 166 dbSNP
rs576337967 170 dbSNP
rs936443598 171 dbSNP
rs1468935097 178 dbSNP
rs979891580 184 dbSNP
rs948504297 185 dbSNP
rs866988519 191 dbSNP
rs925060235 192 dbSNP
rs752218070 193 dbSNP
rs961189115 195 dbSNP
rs557270480 205 dbSNP
rs1324878639 207 dbSNP
rs1438034723 213 dbSNP
rs1257948405 214 dbSNP
rs1461555014 217 dbSNP
rs879475611 218 dbSNP
rs1359515756 222 dbSNP
rs1168375880 230 dbSNP
rs1461447044 231 dbSNP
rs1296047438 237 dbSNP
rs1371060310 240 dbSNP
rs61092614 246 dbSNP
rs1294997162 247 dbSNP
rs954058337 252 dbSNP
rs766823486 253 dbSNP
rs1266306441 258 dbSNP
rs955419270 262 dbSNP
rs1487005309 263 dbSNP
rs1205881017 269 dbSNP
rs761211168 270 dbSNP
rs1255906942 277 dbSNP
rs1028332142 279 dbSNP
rs1190489749 286 dbSNP
rs1419261584 287 dbSNP
rs1028713425 296 dbSNP
rs898492552 301 dbSNP
rs996843307 302 dbSNP
rs542467758 307 dbSNP
rs568273734 308 dbSNP
rs1022384262 313 dbSNP
rs1015710832 315 dbSNP
rs35962613 315 dbSNP
rs1412752980 316 dbSNP
rs1314450238 320 dbSNP
rs772501862 321 dbSNP
rs1196821795 323 dbSNP
rs113129685 324 dbSNP
rs1304974400 328 dbSNP
rs892599769 335 dbSNP
rs1318739656 345 dbSNP
rs548360644 346 dbSNP
rs907384001 347 dbSNP
rs949003390 348 dbSNP
rs894686061 350 dbSNP
rs1054707770 351 dbSNP
rs1349094992 357 dbSNP
rs1004176528 360 dbSNP
rs1230636959 362 dbSNP
rs1159164190 363 dbSNP
rs936356023 367 dbSNP
rs371657859 368 dbSNP
rs186545126 369 dbSNP
rs1375773517 370 dbSNP
rs1409137417 374 dbSNP
rs1328950522 378 dbSNP
rs1390690167 379 dbSNP
rs905146157 382 dbSNP
rs551968693 386 dbSNP
rs1314703317 387 dbSNP
rs1435079949 392 dbSNP
rs1392078547 394 dbSNP
rs945102962 399 dbSNP
rs1346063214 415 dbSNP
rs948412301 417 dbSNP
rs986562302 419 dbSNP
rs1281505256 426 dbSNP
rs762267804 427 dbSNP
rs1028697310 431 dbSNP
rs973999522 435 dbSNP
rs1038049985 437 dbSNP
rs939858454 439 dbSNP
rs774775441 448 dbSNP
rs986748548 451 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' gcGGCCCGAGGGGCCCc 5'
            ||  || :|||||| 
Target 5' ucCCAAGCCUCCCGGGa 3'
11 - 27
2
miRNA  3' gcggcccgAGGGGcccc 5'
                  |:|||    
Target 5' --------UUCCCacuc 3'
1 - 9
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000338961.6 | 3UTR | UUCCCACUCUUCCCAAGCCUCCCGGGACUGGGACAUGUUUGCAAUAAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
119 hsa-miR-4532 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT451366 UQCR11 ubiquinol-cytochrome c reductase, complex III subunit XI 2 2
MIRT451448 ZNF556 zinc finger protein 556 2 4
MIRT458550 CYP2B6 cytochrome P450 family 2 subfamily B member 6 2 2
MIRT460274 SLC26A2 solute carrier family 26 member 2 2 2
MIRT460365 TXNDC16 thioredoxin domain containing 16 2 4
MIRT460539 TM4SF5 transmembrane 4 L six family member 5 2 2
MIRT463626 YY1 YY1 transcription factor 2 2
MIRT468524 SERTAD2 SERTA domain containing 2 2 4
MIRT469966 PTPRF protein tyrosine phosphatase, receptor type F 2 8
MIRT470076 PTGES2 prostaglandin E synthase 2 2 2
MIRT474926 KCTD20 potassium channel tetramerization domain containing 20 2 2
MIRT479976 CARD10 caspase recruitment domain family member 10 2 2
MIRT485533 GPRIN1 G protein regulated inducer of neurite outgrowth 1 2 2
MIRT485939 ECSIT ECSIT signalling integrator 2 4
MIRT486421 RXRA retinoid X receptor alpha 2 2
MIRT487665 HPCAL1 hippocalcin like 1 2 4
MIRT488113 POU3F1 POU class 3 homeobox 1 2 4
MIRT490648 FEM1A fem-1 homolog A 2 2
MIRT491313 LRFN1 leucine rich repeat and fibronectin type III domain containing 1 2 2
MIRT491345 CPNE5 copine 5 2 2
MIRT492688 PHYHIP phytanoyl-CoA 2-hydroxylase interacting protein 2 2
MIRT496879 AHCYL2 adenosylhomocysteinase like 2 2 2
MIRT499243 VAV3 vav guanine nucleotide exchange factor 3 2 4
MIRT508211 SLC35E1 solute carrier family 35 member E1 2 2
MIRT532712 SNRPD3 small nuclear ribonucleoprotein D3 polypeptide 2 2
MIRT540807 SLC35F5 solute carrier family 35 member F5 2 2
MIRT563529 TAF8 TATA-box binding protein associated factor 8 2 2
MIRT607723 LIMS1 LIM zinc finger domain containing 1 2 2
MIRT608089 CRISPLD2 cysteine rich secretory protein LCCL domain containing 2 2 2
MIRT618519 SELPLG selectin P ligand 2 2
MIRT624702 AQR aquarius intron-binding spliceosomal factor 2 2
MIRT624769 AKR1D1 aldo-keto reductase family 1 member D1 2 2
MIRT629974 MRPL36 mitochondrial ribosomal protein L36 2 2
MIRT631355 ZFP82 ZFP82 zinc finger protein 2 2
MIRT631425 CDNF cerebral dopamine neurotrophic factor 2 2
MIRT631664 NDUFV3 NADH:ubiquinone oxidoreductase subunit V3 2 2
MIRT631734 SF3B1 splicing factor 3b subunit 1 2 2
MIRT632333 TCEANC2 transcription elongation factor A N-terminal and central domain containing 2 2 2
MIRT632418 SLC30A5 solute carrier family 30 member 5 2 2
MIRT632530 PSMB2 proteasome subunit beta 2 2 2
MIRT633263 LDLR low density lipoprotein receptor 2 2
MIRT634326 SLC43A2 solute carrier family 43 member 2 2 2
MIRT634752 CRCP CGRP receptor component 2 2
MIRT635411 KIAA1614 KIAA1614 2 2
MIRT636280 RFFL ring finger and FYVE like domain containing E3 ubiquitin protein ligase 2 2
MIRT636290 RAD51L3-RFFL RAD51L3-RFFL readthrough 2 2
MIRT641737 TXNL1 thioredoxin like 1 2 2
MIRT643527 ERAP2 endoplasmic reticulum aminopeptidase 2 2 2
MIRT643554 C11orf70 chromosome 11 open reading frame 70 2 2
MIRT647026 NQO2 N-ribosyldihydronicotinamide:quinone reductase 2 2 2
MIRT647297 RBM43 RNA binding motif protein 43 2 2
MIRT648123 SEMA3E semaphorin 3E 2 4
MIRT648610 TPCN2 two pore segment channel 2 2 2
MIRT648716 IL10RB interleukin 10 receptor subunit beta 2 2
MIRT649424 CDC14B cell division cycle 14B 2 2
MIRT650028 DSG3 desmoglein 3 2 2
MIRT650280 TAS2R5 taste 2 receptor member 5 2 2
MIRT654238 RNF115 ring finger protein 115 2 2
MIRT657031 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT658406 FAM212B family with sequence similarity 212 member B 2 2
MIRT661079 FFAR2 free fatty acid receptor 2 2 2
MIRT661528 NWD1 NACHT and WD repeat domain containing 1 2 2
MIRT661875 PDLIM5 PDZ and LIM domain 5 2 2
MIRT662099 ZNF419 zinc finger protein 419 2 2
MIRT663637 HM13 histocompatibility minor 13 2 2
MIRT663702 ABHD17B abhydrolase domain containing 17B 2 2
MIRT663844 TRIM72 tripartite motif containing 72 2 2
MIRT664768 MESDC2 mesoderm development LRP chaperone 2 2
MIRT665480 VSTM4 V-set and transmembrane domain containing 4 2 2
MIRT666532 RNF157 ring finger protein 157 2 2
MIRT668106 GK5 glycerol kinase 5 (putative) 2 2
MIRT669741 HSPE1-MOB4 HSPE1-MOB4 readthrough 2 2
MIRT671009 MOB4 MOB family member 4, phocein 2 2
MIRT671582 SPIRE2 spire type actin nucleation factor 2 2 2
MIRT673260 INO80 INO80 complex subunit 2 2
MIRT673532 ADRBK2 G protein-coupled receptor kinase 3 2 2
MIRT674713 FAM73A mitoguardin 1 2 2
MIRT675204 ZNF554 zinc finger protein 554 2 2
MIRT676487 DSN1 DSN1 homolog, MIS12 kinetochore complex component 2 2
MIRT676704 GXYLT2 glucoside xylosyltransferase 2 2 2
MIRT676850 ZMYM1 zinc finger MYM-type containing 1 2 2
MIRT676854 RAB3B RAB3B, member RAS oncogene family 2 2
MIRT676914 PHLDA3 pleckstrin homology like domain family A member 3 2 2
MIRT676999 CYP20A1 cytochrome P450 family 20 subfamily A member 1 2 2
MIRT677187 PDE12 phosphodiesterase 12 2 2
MIRT677472 SLC7A11 solute carrier family 7 member 11 2 2
MIRT677561 C19orf52 translocase of inner mitochondrial membrane 29 2 2
MIRT677778 FKTN fukutin 2 2
MIRT677895 DCP1A decapping mRNA 1A 2 2
MIRT677995 GATC glutamyl-tRNA amidotransferase subunit C 2 2
MIRT678238 HMGB1 high mobility group box 1 2 4
MIRT678312 MCM8 minichromosome maintenance 8 homologous recombination repair factor 2 2
MIRT678436 PDE4C phosphodiesterase 4C 2 2
MIRT678479 RNF222 ring finger protein 222 2 2
MIRT678590 ZNF91 zinc finger protein 91 2 2
MIRT678862 SLC7A14 solute carrier family 7 member 14 2 2
MIRT679240 LRP10 LDL receptor related protein 10 2 2
MIRT679387 WDR92 WD repeat domain 92 2 2
MIRT679500 ZNF106 zinc finger protein 106 2 2
MIRT679580 UGGT1 UDP-glucose glycoprotein glucosyltransferase 1 2 2
MIRT679826 TMEM106B transmembrane protein 106B 2 2
MIRT679859 ZFP30 ZFP30 zinc finger protein 2 2
MIRT680472 C3 complement C3 2 2
MIRT683698 LAX1 lymphocyte transmembrane adaptor 1 2 2
MIRT684267 PRPF4 pre-mRNA processing factor 4 2 2
MIRT689404 ZNF573 zinc finger protein 573 2 2
MIRT694756 ZNF843 zinc finger protein 843 2 2
MIRT695955 FANCM Fanconi anemia complementation group M 2 2
MIRT696365 EIF2S3 eukaryotic translation initiation factor 2 subunit gamma 2 2
MIRT700681 PPAP2B phospholipid phosphatase 3 2 2
MIRT701214 ORAI2 ORAI calcium release-activated calcium modulator 2 2 2
MIRT702195 LRRC58 leucine rich repeat containing 58 2 2
MIRT706799 RAI1 retinoic acid induced 1 2 2
MIRT711086 NEUROD2 neuronal differentiation 2 2 2
MIRT715997 RGS12 regulator of G protein signaling 12 2 2
MIRT716399 SEPT5 septin 5 2 2
MIRT718442 RAB11B RAB11B, member RAS oncogene family 2 2
MIRT722159 ARHGAP40 Rho GTPase activating protein 40 2 2
MIRT724960 PTK6 protein tyrosine kinase 6 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-4 Dexamethasone approved 5743 Microarray primary rat thymocytes 20847043 2010 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-4532 Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-4532 Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-4532 Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-4532 Cisplatin 5460033 NSC119875 approved resistant High Gallbladder Cancer cell line (GBC-SD, NOZ)
hsa-miR-4532 Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-4532 Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-4532 Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-4532 Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-4532 Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-4532 Oxaliplatin 6857599 NSC266046 approved sensitive High Colorectal Cancer tissue
hsa-miR-4532 Cisplatin 5460033 NSC119875 approved resistant High Hypopharyngeal Cancer cell line (FaDu)
hsa-mir-4532 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-4532 Cisplatin 5460033 NSC119875 approved sensitive cell line (A2780)
hsa-mir-4532 Cisplatin 5460033 NSC119875 approved resistant cell line (BxPC3)
hsa-miR-4532 Cisplatin 5460033 NSC119875 approved resistant cell line (CAL-27) (mitochondrial RNA)
hsa-miR-4532 Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-4532 Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-4532 Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM36)
hsa-miR-4532 Doxorubicin 31703 NSC123127 approved resistant cell line (HS578T)
hsa-miR-4532 Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-4532 Cisplatin 5460033 NSC119875 approved resistant cell line (A2780)
hsa-miR-4532 Neoadjuvant chemotherapy sensitive tissue (breast cancer)
hsa-miR-4532 Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-4532 Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-4532 Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR4)
hsa-miR-4532 Cisplatin 5460033 NSC119875 approved resistant cell line (OVSAHO)

Error report submission